Skip to content
  • Sunday, 26 July 2026
  • 4:29 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1284: Clinical Update with Dr. Daniel Griffin
Microbiology & Immunology

TWiV 1284: Clinical Update with Dr. Daniel Griffin

Lina Irawan Apr 17, 2026 0

The latest episode of the popular podcast "This Week in Virology" (TWiV), episode 1284, features a comprehensive clinical update from…

Read More
Microbiology & Immunology

TWiV 1286: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 17, 2026 0

In a recent clinical update that has stirred significant concern within the scientific and public health communities, Dr. Daniel Griffin…

Read More
Microbiology & Immunology

TWiV 1288: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 17, 2026 0

In a recent clinical update, virologists Dr. Vincent Racaniello and Dr. Daniel Griffin expressed significant concern and bewilderment regarding proposed…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 16, 2026 0

In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin, in conversation with Vincent…

Read More
Microbiology & Immunology

TWiV 1292: Clinical Update with Dr. Daniel Griffin

Lina Irawan Apr 12, 2026 0

In a stark assessment of the contemporary public health landscape, Dr. Daniel Griffin and Vincent Racaniello, host of the popular…

Read More
Microbiology & Immunology

TWiV 1284: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 10, 2026 0

In a year-end clinical update, Dr. Daniel Griffin, in conversation with Vincent Racaniello on the “This Week in Virology” podcast,…

Read More
Microbiology & Immunology

TWiV 1286: Clinical Update with Dr. Daniel Griffin

Lina Irawan Apr 10, 2026 0

In a recent episode of "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin, a prominent infectious disease clinician, and…

Read More
Microbiology & Immunology

TWiV 1288: Clinical Update with Dr. Daniel Griffin Discusses Alarming Shifts in Childhood Immunization Schedules and Ongoing Public Health Concerns

Lina Irawan Apr 9, 2026 0

In a recent episode of the widely respected podcast "This Week in Virology" (TWiV), Dr. Daniel Griffin, a clinical expert,…

Read More
Microbiology & Immunology

TWiV 1290: Clinical update with Dr. Daniel Griffin | Microbe TV

Lina Irawan Apr 9, 2026 0

In a comprehensive clinical update delivered on the latest episode of "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin…

Read More
Microbiology & Immunology

TWiV 1292: Clinical update with Dr. Daniel Griffin

Lina Irawan Apr 5, 2026 0

The latest installment of "This Week in Virology" (TWiV) podcast, episode 1292, features a comprehensive clinical update from Dr. Daniel…

Read More

Posts pagination

1 … 6 7 8 9
Can the heart heal itself? New study says it canWeekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trialsMIT Researchers Unveil Breakthrough Terahertz Microscope to Observe Quantum Vibrations in Superconducting MaterialsKing’s College London Researchers Identify KCL-286 as a Multitarget Breakthrough for Early-Stage Alzheimer’s Treatment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ